ES2058546T3 - Formulaciones farmaceuticas granulares. - Google Patents

Formulaciones farmaceuticas granulares.

Info

Publication number
ES2058546T3
ES2058546T3 ES89309867T ES89309867T ES2058546T3 ES 2058546 T3 ES2058546 T3 ES 2058546T3 ES 89309867 T ES89309867 T ES 89309867T ES 89309867 T ES89309867 T ES 89309867T ES 2058546 T3 ES2058546 T3 ES 2058546T3
Authority
ES
Spain
Prior art keywords
searching
nucleoar
sea
sugar
nucleo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89309867T
Other languages
English (en)
Inventor
Tarlok Singh Bola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Rorer Ltd
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823082A external-priority patent/GB8823082D0/en
Priority claimed from GB898907658A external-priority patent/GB8907658D0/en
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Application granted granted Critical
Publication of ES2058546T3 publication Critical patent/ES2058546T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

LA INVENCION PROVEE UN PROCESO PARA LA PREPARACION DE GRANULOS COMPRENDIENDO UN FARMACO EL CUAL COMPRENDE PONER EN CONTACTO UN SUBSTRATO PARTICULAR PULVERIZADO Y SECADO Y UN FARMACO PARTICULAR PARA OBTENER PARTICULAS COMPRENDIENDO UN NUCLEO DE SUBSTRATO PORTANDO UN FARMACO ABSORBIDO Y PONER EN CONTACTO ESTAS PARTICULAS CON UN FARMACO PARTICULAR Y UN EXCIPIENTE FARMACEUTICAMENTE ACEPTABLE FUNDIDO O ABLANDADO TERMICAMENTE, EL CUAL ES SOLIDO A TEMPERATURA AMBIENTE PARA OBTENER, DESPUES DE ENFRIAR HASTA SOLIDIFICAR O ENDURECER EL EXCIPIENTE, GRANULOS COMPRENDIENDO UN NUCLEO DE SUBSTRATO POLVERIZADO Y SECADO PORTANDO EXCIPIENTE Y FARMACO ACEPTABLES FARMACEUTICAMENTE.
ES89309867T 1988-09-30 1989-09-28 Formulaciones farmaceuticas granulares. Expired - Lifetime ES2058546T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888823082A GB8823082D0 (en) 1988-09-30 1988-09-30 New compositions of matter
GB898907658A GB8907658D0 (en) 1989-04-05 1989-04-05 New compositions of matter

Publications (1)

Publication Number Publication Date
ES2058546T3 true ES2058546T3 (es) 1994-11-01

Family

ID=26294465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89309867T Expired - Lifetime ES2058546T3 (es) 1988-09-30 1989-09-28 Formulaciones farmaceuticas granulares.

Country Status (16)

Country Link
US (1) US5489439A (es)
EP (1) EP0361910B1 (es)
JP (1) JPH02180813A (es)
AT (1) ATE107854T1 (es)
AU (1) AU623177B2 (es)
DE (1) DE68916497T2 (es)
DK (1) DK481689A (es)
ES (1) ES2058546T3 (es)
FI (1) FI894611A7 (es)
HU (1) HU203967B (es)
IE (1) IE63875B1 (es)
IL (1) IL91836A (es)
NO (1) NO893893L (es)
NZ (1) NZ230836A (es)
PT (1) PT91857B (es)
YU (1) YU189289A (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2941081B2 (ja) * 1991-03-26 1999-08-25 株式会社奈良機械製作所 結晶性有機化合物の非晶質割合の増加と再結晶化を抑制する方法
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JP3761649B2 (ja) * 1996-12-11 2006-03-29 住友化学株式会社 粒状農薬組成物の製造方法
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
EP2295043A1 (en) 1999-10-29 2011-03-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
MY148466A (en) * 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
JP4732696B2 (ja) 2002-04-09 2011-07-27 フラメル・テクノロジー 活性成分の改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006074185A2 (en) * 2005-01-06 2006-07-13 Cima Labs Inc. Taste masking system for non-plasticizing drugs
WO2006116247A1 (en) * 2005-04-25 2006-11-02 Teva Pharmaceuticals Usa, Inc. Extended release formulations
US9023400B2 (en) * 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
EP1972336A1 (en) * 2007-03-19 2008-09-24 LEK Pharmaceuticals D.D. Hot-melt micropellets
ATE515259T1 (de) * 2007-05-29 2011-07-15 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit eszopiclon
AU2010223105B2 (en) 2009-03-09 2016-05-12 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
PL2826467T3 (pl) 2010-12-22 2018-01-31 Purdue Pharma Lp Zamknięte, zabezpieczone przed manipulowaniem formy dozowania o kontrolowanym uwalnianiu
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
JP6255908B2 (ja) * 2012-11-09 2018-01-10 大正製薬株式会社 固形製剤
PE20151301A1 (es) 2013-02-05 2015-09-16 Purdue Pharma Lp Formulaciones farmaceuticas resistentes a la manipulacion indebida
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
DE2028224A1 (de) * 1969-06-10 1970-12-17 Solco Basel AG, Basel (Schweiz)j Oral anwendbare Arzneimittelform
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
AT385654B (de) * 1984-09-04 1988-05-10 Arcana Chem Pharm Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung
EP0192321A3 (en) * 1985-01-19 1987-09-02 Beecham Group Plc Enteric coated allergen pharmaceutical composition
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.

Also Published As

Publication number Publication date
AU623177B2 (en) 1992-05-07
YU189289A (en) 1991-04-30
HUT53282A (en) 1990-10-28
AU4241689A (en) 1990-04-05
HU203967B (en) 1991-11-28
JPH02180813A (ja) 1990-07-13
EP0361910B1 (en) 1994-06-29
IL91836A0 (en) 1990-06-10
FI894611L (fi) 1990-03-31
NZ230836A (en) 1990-07-26
PT91857B (pt) 1995-07-03
ATE107854T1 (de) 1994-07-15
IE893132L (en) 1990-03-30
NO893893L (no) 1990-04-02
DK481689A (da) 1990-03-31
IE63875B1 (en) 1995-06-14
EP0361910A1 (en) 1990-04-04
DE68916497D1 (de) 1994-08-04
DK481689D0 (da) 1989-09-29
FI894611A7 (fi) 1990-03-31
US5489439A (en) 1996-02-06
NO893893D0 (no) 1989-09-29
IL91836A (en) 1994-12-29
DE68916497T2 (de) 1994-11-17
FI894611A0 (fi) 1989-09-28
PT91857A (pt) 1990-03-30

Similar Documents

Publication Publication Date Title
DE68916497D1 (de) Pharmazeutisches Granulat.
IS1843B (is) Aðferð til að framleiða kristallaða amifostínblöndu ásamt skammtaformum af kristölluðu amifostíni
FI88577C (fi) Kontinuerligt foerfarande foer tabletering av extruderbara farmaceutiska blandningar
PT89260A (pt) Processo de preparacao de uma composicao farmaceutica granular a base de cimetidina e de comprimidos a partir daquela
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
SE8204581L (sv) Farmaceutiska excipienter
NO952110L (no) Termisk granuleringsfremgangsmåte
DK0391374T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter
IT8421488A0 (it) Procedimento per la produzione disolfato potassico e di solfati potassico magnesiaci granulati, e granulati cosi' prodotti.
FI891004A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
DK0733363T3 (da) Fremgangsmåde til fremstilling af risledygtig R,S-thioctsyre, R,S-thioctsyregranulater samt anvendelsen heraf
DK102892A (da) Purin-derivater, farmaceutisk praeparat omfattende forbindelserne samt forbindelser til brug som mellemprodukter
IT8247787A0 (it) Procedimento per la produzione dicorpi sagomati dotati di elevata stabilita' meccanica ad alta temperatura per isolamenti termici, eprodotto ottenuto
IT8921525A0 (it) Procedimento per la preparazione di corpi formati strutturali e termoisolanti e prodotti cosi' ottenuti.
ATE374027T1 (de) Eine kondensierte indolverbindung enthaltendes arzneimittel
IT8519621A0 (it) Derivati di omocisteina tiolattone,loro procedimento di preparazione e formulazioni farmaceutiche
OA09487A (fr) "Procédé de préparation de nouvelles pyrrolo (1,2-a)thiéno (3,2-f) diazépines(1,4)".
FI832108A7 (fi) Terapeuttisesti käyttökelpoiset tetraliinijohdannaiset III, menetelmät tällaisten yhdisteiden valmistavalmistamiseksi ja farmaseuttiset valm isteet tällaisille yhdisteille.
IT8722079A0 (it) Derivati dell'acido 2-osso-1-azetidin solfonico dotati di attivita' antibatterica, procedimento per la loro preparazione e relative formulazioni farmaceutiche.
ES503533A0 (es) Torre para el enfriamiento de productos granulosos,especial-mente agricolas.
AR220133Q (es) Procedimiento de obtencion de preparaciones solidas de medicamentos muy poco solubles,al estado muy finamente dividido
IT1230704B (it) Composizione farmaceutica per il trattamento di ictus ischemico.
DK441689D0 (da) Hidtil ukendt thieno(3',4'-4,5)imidazo(2,1-b)-thiazol-derivater med laegemiddelvirkning og fremgangsmaade til fremstilling deraf
IT8019354A0 (it) Derivati dell'acido nicotinico adattivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8124704A0 (it) Derivati dell'acido 7-aciloamidocefasporanico tiolato, suoi sali, preparati farmaceutici a base di tali derivati e procedimenti per la loro fabbricazione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 361910

Country of ref document: ES